iRhythm Securities Settlement
iRhythm Technologies and its executives made false and misleading statements overhyping the real-time capabilities and market role of its Zio AT heart monitor. Affected investors who file a valid claim can receive a proportional cash distribution to compensate for financial losses stemming from subsequent stock price declines.
Payout amount
Amount TBD
Deadline to claim
Expired
Eligibility
Eligibility: • All persons or entities who purchased or otherwise acquired iRhythm Technologies, Inc. (NASDAQ: IRTC) common stock during the specified class window. • Investors who suffered documented financial damages tied to the artificial inflation of the stock price. • Excludes the defendants, corporate officers, directors, their immediate families, affiliates, and any judicial officers presiding over the case.
